Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)
| Country | United States |
|---|---|
| Deadline | 2027-06-02 (192 days left) |
| Published | 2024-10-31 |
| Sectors | Health & life sciences, Research & innovation |
| Source | Grants.gov (US) |
Summary
Funding opportunity PAR-25-211. CFDA: 93.393, 93.121, 93.213, 93.313, 93.866
The buyer, the value, the full description and the link to the official notice are available with a free account.